Pharmaceutical Sector

Here's the backstory of Biocon's Alzumab which has been approved by the CDSCO for the treatment of Covid-19 in India

The firm is charting a turnaround plan by beginning the manufacturing of key bulk drugs that the government has identified under a production-linked incentive (PLI) scheme

The potential vaccine has received a certificate from the National Medical Products Administration to launch clinical trials

The tablet is the generic of Janssen Pharmaceuticals Inc's reference listed drug product Xarelto

Economic delinking with China makes no sense for India; investment, growth and public welfare will suffer

A post Covid-19 foreign trade policy must be cognisant of the evolving opportunities and challenges in services trade and must prepare domestic policies and capacity accordingly

The two companies had previously entered into a similar agreement in February 2018 for promotion and distribution of tocilizumab (Actemra) and other products

The state signs MOUs with four leading industrial bodies to create employment for 1.1 mn returning migrants

Export growth started declining in February and turned negative in March, at -23.24 per cent

Domestic growth rebounds to double digits; will keep overall momentum on even keel

IP regimes should not outweigh public health interests

We should question the wisdom and morality of a system that silently condemns millions of human beings to suffering

It is not just that we all, in our personal lives, have rediscovered to our dismay that dependence on too many other people leaves us exposed during crises

Announces one API, one medical device park in Gujarat

Metropolis Healthcare, Bliss GVS Pharma, RPG Life Sciences, Dr. Lal PathLabs, Biocon, Albert David and FDC from the index were up more than 3 per cent.

In the 2020-21 Union Budget, finance minister Nirmala Sitharaman proposed to expand the scheme to all districts, and offer 2,000 medicines and 300 surgicals by 2024

Aspen Pharmacare has abandoned its dividend this year and is selling assets to pay down debt after levels moved close to breaching debt covenants

Revenue growth, margins have been trending up over the past couple of quarters

First Indian firm to get contract for supplying generic schizophrenia drug to public hospitals there

It has also been a decade of major mergers and acquisitions, the most noteworthy one perhaps being the Sun Pharma-Ranbaxy deal